Skip to main navigation Skip to search Skip to main content

Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial

  • Alexander M.M. Eggermont
  • , Michal Kicinski
  • , Christian U. Blank
  • , Mario Mandala
  • , Georgina V. Long
  • , Victoria Atkinson
  • , Stéphane Dalle
  • , Andrew Haydon
  • , Adnan Khattak
  • , Matteo S. Carlino
  • , Shahneen Sandhu
  • , James Larkin
  • , Susana Puig
  • , Paolo A. Ascierto
  • , Piotr Rutkowski
  • , Dirk Schadendorf
  • , Rutger Koornstra
  • , Leonel Hernandez-Aya
  • , Anna Maria Di Giacomo
  • , Alfonsus J.M. Van Den Eertwegh
    • Jean Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul C. Lorigan, Clemens Krepler, Nageatte Ibrahim, Sandrine Marreaud, Alexander Van Akkooi, Caroline Robert, Stefan Suciu

Research output: Contribution to journal › Article › peer-review

391   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Association between Immune-Related Adverse Events and Recurrence-Free Survival among Patients with Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary Analysis of a Randomized Clinical Trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience